UNITED STATES
SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934 Date of Report:   January 27, 2005
(date of earliest event reported) VASCULAR SOLUTIONS, INC.
(Exact name of registrant as specified in its charter) Commission File Number: 0-27605_____________ Minnesota
     41-1859679(State or other jurisdiction of incorporation)
     (IRS Employer Identification No.) 6464 Sycamore CourtMinneapolis, Minnesota 55369(Address of principal executive offices) (763) 656-4300
(Registrants telephone number, including area code) Not Applicable
(Former name or former address, if changed since last report) Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions: o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) oSoliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) oPre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) oPre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


# Item 2.02. Results of
Operations and Financial Condition

The
following information is being furnished in accordance with Item 2.02 of Form
8-K and shall not be deemed filed for purposes of Section 18 of the Exchange
Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as amended, or
the Exchange Act, except as expressly set forth by specific reference in such filing:

| | On
January 27, 2005, Vascular Solutions, Inc. issued a press release to report the
Companys results of operations and financial condition for the completed fiscal year
ended December 31, 2004. The release is furnished as Exhibit 99.1 hereto and is
incorporated herein by reference.
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

# Item 9.01. Financial
Statements and Exhibits

(c) The
following exhibit is being furnished in accordance with Item           2.02
of Form 8-K and shall not be deemed filed for purposes of           Section
18 of the Securities Exchange Act of 1934, as amended (the           Exchange Act),
or otherwise subject to the liabilities of that           section, nor shall it be deemed
to be incorporated by reference in any filing           under the Securities Act of 1933,
as amended, or the Exchange Act, except as           expressly set forth by specific
reference in such filing:

99.1
  Press Release, dated January 27, 2005, of Vascular Solutions, Inc.

# SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.

|                       | VASCULAR SOLUTIONS, INC.
|---------------------- | ------------------------
|                      
|                      
|Date: January 27, 2005 |                         
|                       |                         
|                       |                         
|                       |                         

---

EXHIBIT INDEX





|Exhibit No. |  | Description                                                      
|----------- |  | -----------------------------------------------------------------
|99.1        |  | Press Release dated January 27, 2005, of Vascular Solutions, Inc.







---